Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort.
DeMichele A, Aplenc R, Botbyl J, Colligan T, Wray L, Klein-Cabral M, Foulkes A, Gimotty P, Glick J, Weber B, Stadtmauer E, Rebbeck TR.
DeMichele A, et al. Among authors: aplenc r.
J Clin Oncol. 2005 Aug 20;23(24):5552-9. doi: 10.1200/JCO.2005.06.208.
J Clin Oncol. 2005.
PMID: 16110016
Retracted.